NCT00139724View on ClinicalTrials.gov

Evaluate Efficacy and Safety Of Tolterodine Extended Release Capsule Compared With Tolterodine Immediate Release Tablet

PHASE3CompletedINTERVENTIONAL
Enrollment

260

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

October 31, 2006

Study Completion Date

October 31, 2006

Conditions
Urinary Incontinence
Interventions
DRUG

tolterodine extended release capsule

Trial Locations (7)

100020

Pfizer Investigational Site, Beijing

100034

Pfizer Investigational Site, Beijing

Pfizer Investigational Site, Beijing

200040

Pfizer Investigational Site, Shanghai

200127

Pfizer Investigational Site, Shanghai

310003

Pfizer Investigational Site, Huangzhou

Unknown

Pfizer Investigational Site, Chongqing

All Listed Sponsors
lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT00139724 - Evaluate Efficacy and Safety Of Tolterodine Extended Release Capsule Compared With Tolterodine Immediate Release Tablet | Biotech Hunter | Biotech Hunter